346 related articles for article (PubMed ID: 17932356)
21. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
22. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
[TBL] [Abstract][Full Text] [Related]
23. LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer.
Kyndi M; Alsner J; Hansen LL; Sørensen FB; Overgaard J
Acta Oncol; 2006; 45(5):602-9. PubMed ID: 16864176
[TBL] [Abstract][Full Text] [Related]
24. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
[TBL] [Abstract][Full Text] [Related]
26. Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary.
Anna L; Holmila R; Kovács K; Gyorffy E; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Husgafvel-Pursiainen K; Schoket B
Mutagenesis; 2009 Nov; 24(6):475-80. PubMed ID: 19643813
[TBL] [Abstract][Full Text] [Related]
27. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
28. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
30. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
31. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
32. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
[TBL] [Abstract][Full Text] [Related]
33. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
[TBL] [Abstract][Full Text] [Related]
34. Germline TP53 mutations and single nucleotide polymorphisms in children.
Valva P; Becker P; Streitemberger P; Lombardi GM; Rey G; Guzman CA; Preciado MV
Medicina (B Aires); 2009; 69(1 Pt 2):143-7. PubMed ID: 19414295
[TBL] [Abstract][Full Text] [Related]
35. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
36. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
37. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran.
Nadji SA; Mahmoodi M; Ziaee AA; Naghshvar F; Torabizadeh J; Yahyapour Y; Nategh R; Mokhtari-Azad T
Lung Cancer; 2007 May; 56(2):145-51. PubMed ID: 17208332
[TBL] [Abstract][Full Text] [Related]
38. Age-related function of tumor suppressor gene TP53:contribution to cancer risk and progression.
Cherdyntseva NV; Gervas PA; Litvyakov NV; Stakcheeva MN; Ponomaryeva AA; Dobrodeev AY; Denisov EV; Belyavskaya VA; Choinzonov EL
Exp Oncol; 2010 Sep; 32(3):205-8. PubMed ID: 21403619
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
40. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
